OBJECTIVE: Human adipocytes can be obtained in vitro by differentiation of human preadipocytes or mesenchymal stem cells (hMSC). Although functionally similar to freshly isolated cells, no detailed comparison of the different cell types has been performed. The antilipolytic a2A-adrenoceptor (AR) and the cAMP-degrading enzyme Phosphodiesterase-3B (PDE3B) have been implicated in the fine-tuning of lipolysis but little is known regarding their role in human adipocytes nor whether their expression and/or function differs in fat cells from different precursors.
Introduction
Mammal adipocytes display at least two unique traits compared to nonfat cells. They store energy in the form of triglycerides (TGs) through an insulin-stimulated process termed lipogenesis. While TG turnover is achieved via lipolysis where TGs are hydrolyzed by hormone-sensitive lipase (HSL) releasing glycerol and free fatty acids. HSL is stimulated by the natural catecholamines adrenaline (A) and noradrenaline (NA) binding to any of the three b-adrenoceptors (b1Àb3-AR) and is inhibited by the same ligands activating a2-adrenoceptors. Unlike adipocytes of most other species, the four lipolysis regulating adrenoceptor subtypes are functional in human fat cells. 1 There are several a2-adrenoceptor subtypes but human adipocytes express only the a2A variant (a2A-AR). 2 b-and a2A-adrenoceptor (a2A-AR)
are coupled to intramembranous G-proteins that activate (Ga s ) or inhibit (Ga i ) adenylyl cyclase, respectively, resulting in increased or decreased levels of cyclicAMP (cAMP). 3 cAMP activates protein kinase A (PKA), which phosphorylates and activates several proteins in the lipolytic cascade, primarily HSL. Since A/NA bind to both b-and a2A-AR, the end result on lipolysis is pending on the relative expression and activity of the cell surface receptors of a specific cell. Regulation of cAMP levels is also achieved at another level by phosphodiesterases (PDEs), a family of enzymes that degrade cAMP upon activation by antilipolytic hormones such as insulin. The main subtype of PDE in human adipose tissue is phosphodiesterase-3B (PDE3B). 4 Insulin stimulation in adipocytes results in insulin receptor autophosphorylation and binding of adapter proteins, including insulin receptor substrate-1 (IRS-1). The adapter proteins recruit several effectors including phosphatidyl inositol triphosphate kinase (PI3-K). The phosphatidyl tri-phosphate lipid formed by phosphorylation of PI3-K works as an anchor molecule and recruits the PDK1/2 kinase to the plasma membrane. PDK1/2 phopshorylates protein kinase B (PKB), the enzyme responsible for phosphorylating and activating PDE3. This signaling cascade results in decreased cAMP concentrations, which leads to decreased PKA activity and dephosphorylation of HSL. In human adipocytes insulininduced antilipolysis is completely counteracted by the selective PDE3-inhibitor OPC3911. 5 In combination with other studies, 6 this indicates that PDE3 activation is the main in vivo mechanism for the antilipolytic effect of insulin. During the last decades several synthetic compounds have been synthesized with both agonist and antagonist effects specific for ARs. Among these are the agonists isoprenaline (specific for b1-b3), dobutamine (b1), terbutaline (b2), clonidine (a2) and the antagonists propranolol (b1 and b2), metoprolol (b1) and yohimbine (a2). With the use of these pharmacological agents previous work has demonstrated that murine adipocytes in comparison with human adipocytes express very few a2A-ARs. 1, 3 Thus, while incubation with NA in murine primary adipocytes or cell lines generates a full b-agonist response, stimulation with the same agents in human adipocytes results in an attenuated lipolytic response. Co-incubation with NA and the a2-blocker yohimbine restores lipolysis to levels comparable to that of cells stimulated with isoprenaline alone. The functional importance of the marked a2A-AR effect in human cells is not entirely clear but it has been speculated that an increased antilipolytic response to catecholamines may promote fat accumulation in adipocytes. 7 In line with this, previous work has shown that adipocytes from infant subjects display a lower lipolytic capacity than that observed in adipocytes from adults. 8 This may constitute a mechanism that promotes fat cell growth and secures energy storage in the growing fat cell. Adipocytes develop in the tissue itself but can also be generated in vitro by incubation of immature precursor cells in the presence of specific factors. In human adipocyte research freshly isolated mature fat cells have constituted a well-established model system. These cells are sensitive and survive only a few hours following isolation. We and others have shown that adipocyte-like cells can be obtained from human mesenchymal stem cells (hMSC) 9, 10 as well as fibroblast-like cells in the adipose tissue stroma, often referred to as preadipocytes. 11 These cells develop from similar albeit not identical precursors. Both preadipocytes and differentiated hMSC appear to retain several phenotypic characteristics of a mature organ cell indicating that maturation ex vivo is functional given the right conditions. 12 However, although similar, there may be important differences in these cells compared to mature fat cells. In an effort to define possible differences between these cell systems in the regulation of lipolysis we studied the functional importance of a2A-AR and PDE3B by stimulating lipolysis with NA and 8-bromo (8b)cAMP in the presence or absence of the specific inhibitors yohimbine and OPC3911. In addition, we determined the mRNA and protein expression of both a2A-AR and PDE3B as well as the enzymatic activity of PDE3B in the different cell types.
Materials and methods
Adipocyte cell culture For mature adipocytes and preadipocyte cultures fat was obtained from 13 female subjects who were undergoing cosmetic mastectomy or abdominal surgery. Assessment of differentiation Differentiation of preadipocytes and hMSC was assessed by determining glycerol-3-phosphate-dehydrogenase (GPDH) activity and staining with the triglyceride-specific dye Oil Red O as described before.
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RNA isolation and real-time PCR Total RNA was extracted from human isolated adipocytes, preadipocytes and hMSC using the RNeasy mini kit (Qiagen GmbH, Hilden, Germany) and the RNA concentration and purity were assessed spectrophotometrically. About 1 mg of total RNA from each sample was reverse transcribed to cDNA using the Omniscript RT kit (Qiagen GmbH, Hilden, Germany) and random hexamers (Invitrogen, Tåstrup, Denmark). Quantitative real-time PCR (RT-qPCR) was performed on an iCycler IQ (Bio-Rad Laboratories, Hercules, CA, USA). PDE3 B and a2A-AR mRNA were quantified using SYBR Green-based technology with 5 ng cDNA used in 25 ml PCR reactions in duplicates. As internal control the gene 18S was used. The primer pairs were designed to span exon-intron boundaries and generate a single amplicon according to dissociation curves and agarose gel electrophoresis. Primer sequences were for a2A-AR 
Lipolysis
Lipolysis experiments were performed as described previously. 14 For preadipocytes and hMSC-derived adipocytes, cells were washed with DMEM/NUT.MIX.F-12 medium and then incubated in duplicates for 3 h at 371C with DMEM/ NUT.MIX.F-12 medium containing 20 g/l BSA. For mature fat cells, incubations were performed for 2 h at 371C on shaking water bath. The following concentrations were used for each agent: 0.1 mM NA, 0.1 mM of the a 2 -adrenoceptor blocker yohimbine, 1 mM of the phosphodiesterase-sensitive cAMP analog 8-b cyclic AMP and 3 mM OPC3911. Incubation without drugs was made to determine basal lipolysis. Following incubation, medium was removed and kept at À201C for subsequent measurement of glycerol concentration (an index of lipolysis) using a bioluminescence method. 18 To control for interexperimental differences in adipocyte differentiation of preadipocyte and hMSC-derived adipocyte cultures, release of glycerol was expressed as the concentration in the medium per GPDH activity and protein amount. For protein measurements cells were lysed in a prechilled protein lysis buffer containing 50 mM Tris pH 7.6, 150 mM NaCl, 1% Triton X-100, 0.1 M PMSF and protease inhibitors as described previously. 19 Protein content was assayed using BCA Protein Assay Reagent Kit (PIERCE, Rockford, IL, USA) on 96-well microtiter plates with BSA as a standard. Measurements were performed on a spectrophotometer in accordance with the guidelines given in the kit.
Western blot
Total cytosolic extracts were obtained by lysing the cells in ice-cold buffer, 1% Triton X-100 in 50 mM Tris pH 7.6. and 150 mM NaCl supplemented with protease inhibitors (Complete s , Roche Diagnostics, Switzerland and 1 mM PMSF). Cell lysates were centrifuged at 14 000 r.p.m for 30 min at þ 41C and the supernatant was removed to new tubes. The total amount of protein was measured using the BCA protein assay kit (Pierce, Rockford, IL, USA). Equal amounts of cell lysates (150 mg) from each sample were boiled in 1 Â SDSloading buffer for 5 min and loaded and separated by SDSpolyacrylamide gel electrophoresis. Proteins were then transferred onto PVDF membranes (Amersham, Little Chalfont, UK) by Western blotting. Blots were blocked for 1 h at room temperature in Tris-buffered saline, with 0.1% Tween 20 (TBS-T) and 5% nonfat dried milk, and subsequently incubated overnight at þ 41C in the presence of antibodies directed against a2A-AR, Ga i and Ga s (all from Santa Cruz, CA, USA). Following washing steps in TBS-T and incubation Differential role of a2A-AR and PDE3 A Dicker et al with secondary antibodies conjugated to horseradish peroxidase, antigen-antibody complexes were detected by chemiluminescence (Supersignal s , Pierce, Rockford, IL, USA) and exposed to high-performance chemiluminescence film (Amersham Pharmacia, Little Chalfont, UK). Films were scanned and specific bands were quantified using the NIH Image software. To control for inter-experimental differences in loading, protein retrieval, transfer, etc. blots were subsequently washed and reprobed with an antibody directed against b-actin (Sigma, St Louis, MO, USA).
Assay of PDE3B activity
The PDE assay is based on the following reaction: cAMP to AMP (catalyzed by PDE) and then the conversion of AMP to adenosine via 5 0 -nucleotidase. Differentiated preadipocytes and hMSC as well as mature adipocytes were homogenized in a buffer containing 50 mM TES, 250 mM sucrose, 1 mM EDTA, 0.1 mM EGTA (pH 7.5) and Complete (Roche Diagnostics, Switzerland). The cell homogenates were incubated at 301C for 20 min in a total volume of 300 ml containing 50 mM HEPES (pH 7.4), 0.1 mM EGTA and 0.5 mM 
Statistical analysis
Values are given as mean7standard deviation (s.d.) for mRNA and PDE assay data and as mean7standard error (s.e.) for lipolysis. They were compared with Student's unpaired t-test or Kruskal-Wallis' nonparametric test as indicated using standard software packages.
Drugs and chemicals BSA fraction V (lot no. A-9418), 8-bromocAMP, glucose, glycerol kinase, NA, Oil Red O and yohimbine were obtained from Sigma Chemical (Sigma, St Louis, MO, USA). OPC 3911 was obtained from Otsuka Pharmaceuticals, Japan. All chemicals used were of the highest grade of purity that was commercially available.
Results
hMSC-derived adipocytes display a pronounced a2A-AR but not PDE3B effect Adipocytes differentiated from hMSC of adult BM were generated as described in the method section. We have previously demonstrated that fat cells derived with this protocol express similar, if not identical, levels of adipocytespecific proteins (including HSL and b2-AR) as human preadipocytes. 10 Moreover, the differentiation status of these cells was determined by assessing the activity of GPDH and did not differ significantly between these cells and differentiated preadipocytes (data not shown). Cells were stimulated with lipolytic agents and lipolysis was determined by assessing glycerol release in the medium. The lipolytic rate was expressed as percent over basal lipolysis (the lipolytic rate in control cells incubated in medium alone). Incubation with 0.1 mM NA resulted in decreased lipolysis compared with control cells (À47.676.0%, Figure 1 ). This was due to a potent stimulation of a2A-AR since co-incubation with 0.1 mM of the a2-AR antagonist yohimbine, a concentration commonly used in our laboratory, resulted in a restored lipolytic effect (297752.5%, P ¼ 0.001). Yohimbine alone did not influence basal lipolysis (data not shown). One millimolar of the cAMP analog 8bcAMP activated lipolysis to a minor degree (113.5727.1%). Concomitant incubation with 8bcAMP and 3 mM of the PDE3 inhibitor OPC3911 did not lead to a significant increase in lipolysis (218769.2%, P ¼ 0.094), indicating that PDE3B activity in these cells does not influence triglyceride hydrolysis to a substantial degree. NA n =6 NA+ Yoh n =6 8bcAMP n =4 8bcAMP+OPC n =4 Figure 1 Lipolysis in hMSC-derived adipocytes. Cells were stimulated with either NA (NA) with or without the a2A-AR blocker yohimbine (NA þ Yoh), or the phosphodiesterase 3 (PDE3) sensitive cAMP analog 8bcAMP with or without the PDE3-specific inhibitor OPC3911 (8bcAMP þ OPC). Glycerol release was measured in the medium after 3 h of incubation and expressed relative to GPDH activity and protein concentration. Basal lipolysis was set to 100% for each experiment, which was repeated at least four times with cells from different donors. Owing to the strong antilipolytic effect of a2A-AR, NA lowered lipolysis compared to control cells. In the presence of yohimbine, NAstimulated lipolysis was restored to more than three times over basal level. In contrast, addition of OPC to 8bcAMP had no significant effect on lipolytic rate (***, statistically significant over basal lipolysis Po0.001, NS ¼ nonsignificant difference, Student's t-test).
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Preadipocytes display both a2A-AR and PDE3B effects Human preadipocytes were stimulated in similar experiments. In these cells NA stimulated lipolysis approximately 5-fold (442785.7%, Figure 2 ). Co-incubation with yohimbine significantly enhanced the lipolytic effect (8837119%, P ¼ 0.0003). Once again, yohimbine alone did not influence basal lipolysis (data not shown). The lipolytic effect of 8bcAMP was similar to that of NA (5277109%). However, co-incubation with 8bcAMP and OPC3911 resulted in a greatly enhanced effect (15967232%, P ¼ 0.0001) indicating that PDE3B is active in these cells.
Mature adipocytes display both a2A-AR and PDE3B activity Fresh mature adipocytes were isolated and incubated in the presence of NA. In these cells lipolysis was induced three-fold (225738.2%, Figure 3 ). In accordance with previous studies, yohimbine had only a minor effect on NA-induced lipolysis (316766.2%, P ¼ 0.048) and did not influence basal lipolysis (data not shown). Similar to the findings in preadipocytes, 8bcAMP induced a similar lipolytic response as that by NA (180771.4%). Moreover, the addition of OPC 3911 resulted in a markedly elevated lipolytic response (494797.1%, P ¼ 0.0012).
Differences in a2A-AR and PDE3B effects
Our results indicate that the importance of a2-AR and PDE3B in regulating lipolysis is inversely regulated in adipocytes of different origin. To estimate the contribution of these factors in affecting lipolysis, we expressed the lipolytic activity in the presence of either NA þ yohimbine or 8bcAMP þ OPC relative to that of NA or 8bcAMP alone. In hMSC-derived adipocytes the a2A-AR effect was pronounced (168729.6%, Figure 4 ). The effect in mature adipocytes was limited (36.8713.4%, P ¼ 0.0015) while preadipocytes displayed an intermediate effect (114725%). In contrast, the relative importance of PDE3B was marked in mature adipocytes and preadipocytes (3967130 and 235767.1%, respectively) while the PDE3 activity in hMSC-derived adipocytes was low (43.8713.8%, P ¼ 0.036). Taken together, these data suggest that the role of a2A-AR in regulating lipolysis is more pronounced in cells derived from more immature precursors (hMSC-adipocytes4preadipocytes4mature adipocytes) while the reverse is observed for PDE3B activity (mature adipocytes4 preadipocytes4hMSC-adipocytes).
a2A-AR and Ga i mRNA and protein expression
In order to determine whether the differences in effects could be attributed to variations in gene expression we performed reverse transcription followed by real time PCR on RNA isolated from the three cell types. Messenger RNA encoding a2A-AR was similar in preadipocytes and hMSC (0.2370.04 and 0.1670.06 AU, respectively) while adipocytes displayed higher expression (1.0370.69 AU, Figure 5a ). Since the mRNA expression did not correlate with the observed effect of a2A-AR inhibition, we investigated Differential role of a2A-AR and PDE3 A Dicker et al (0.7370.20 AU) and low in hMSC-derived adipocytes, (0.5170.27 AU, P ¼ 0.04, Figure 6a ). Since mRNA expression is a poor indicator of functional activity, we determined the activity of PDE3B in the three cell types with a sensitive assay. In agreement with the previously observed OPC3911 effect we detected a similar stepwise activity where mature adipocytes displayed the highest activities followed by preadipocytes and hMSC adipocytes (Figure 6b ).
Discussion
In this work we have compared the relative importance of a2A-AR and PDE3B for lipolysis in three different types of differentiated human adipocytes. With the use of specific inhibitors we demonstrate that hMSC-derived adipocytes display an important difference compared to freshly isolated mature fat cells. This is the pronounced effect of the antilipolytic a2A-AR, which appears to play a unique role in human fat cells. In contrast, the antilipolytic activity of PDE3B is significantly higher in mature fat cells than hMSCderived adipocytes. In both cases preadipocytes appear to express intermediate effects of a2A-AR and PDE3B inhibition. Since both hMSC and preadipocytes are differentiated in vitro from immature precursors that may or may not be identical to those in the in vivo situation, our results demonstrate that there are quantitative and possibly qualitative differences between mature adipocytes and in vitro differentiated fat cells. The marked effect a2A-AR inhibition observed in hMSC and preadipocytes differs from that in mature fat cells or murine adipocytes and cell lines. The role of a2A-AR in human adipogenesis is not entirely clear. Overexpression of human a2A-AR in mice homozygous for a null mutation in the b3-AR gene promotes high-fat diet obesity, primarily by adipocyte hyperplasia. 7 This would suggest that a2A-AR expression is associated with increased adipocyte proliferation and not hypertrophy. However, several reports have demonstrated that mature fat cells from obese subjects display increased a2A-AR expression, a2A/bÀAR ratios and a2A-AR responsiveness compared to cells from lean subjects [20] [21] [22] [23] This has led to the hypothesis that an enhanced a2A-AR effect is a prerequisite for the well-established obesity-associated fat cell hypertrophy. Moreover, studies in rabbits have demonstrated that a2A-AR responsiveness and expression increases with age, which could explain the correlation between increased age and total fat mass. 24 The environmental cues that mediate these transitions remain to be defined. Taken together, results from animal and human studies suggest that a2A-AR could play a role both in the development of fat cell number and size. In our experiments the a2A-AR effect was highest in hMSC-derived adipocytes, intermediate in preadipocytes and lowest in mature fat cells. It is tempting to speculate that an underlying reason could be that hMSC-derived cells develop from a slightly more immature precursor retaining a more proliferative competence, while preadipocytes develop from a more mature precursor cell with little cell-dividing capacity. An increased importance of a2A-AR would also promote the growth of intracellular TG stores, a necessary step for the developing adipocyte. In agreement with this hypothesis, we have performed experiments on adipocytes derived from hMSC of human fetal liver. In these cells, developed from a more immature precursor than adult BM cells, the a2A-AR effect is even more pronounced (data not shown). The molecular mechanisms remain to be defined. Although a2A-AR mRNA is higher in mature adipocytes (data herein) the protein levels are similar between mature and in vitro differentiated adipocytes demonstrating that the differences in response to a2A-AR inhibition are independent of a2A-AR expression. In contrast, there was a significant differential expression of Ga i 2 mRNA and Ga i protein with the highest levels in hMSCs. It is therefore tempting to speculate that the pronounced effect of yohimbine relies primarily on an Differential role of a2A-AR and PDE3 A Dicker et al enhanced antilipolytic signaling efficiency at the postreceptor level. In contrast to the reduced effect of a2A-AR inhibition in mature fat cells, the effect of PDE3 appears to be increased. This is most probably due to an increased PDE3B mRNA expression resulting in increased activity. The reason for this is not clear. PDE3 is the major effector of insulin's antilipolytic effect. Increased PDE3 activity could therefore reflect a more advanced level of lipolytic regulation in the mature fat cells, where lipolysis is not only regulated by catecholamines but also by insulin. However, further studies are warranted in order to determine whether the differences in expression depend on primary differences between the cell types or due to the in vitro differentiation procedure.
The hMSC, can be obtained from several tissues including adult BM or fetal liver. 10 These cells can be expanded to large numbers and retain the ability to differentiate into cells of mesenchymal origin for example, muscle, bone, cartilage and adipose cells. 25 The selective differentiation is dependent on specific environmental cues, usually a combination of growth factors and cytokines supplied in vitro. hMSC research has spurred much interest in recent years due to the attractive possibility of replacing malfunctioning or dead cells with newly differentiated cells obtained from the patient's own BM. This would also imply that differentiated hMSC can be used as a renewable cellular source which would benefit several areas of research. In particular, human adipocyte research is hampered by the lack of human fat cell lines and most studies are therefore performed on immortalized rodent cell lines such as 3T3-L1 or primary cultures of human preadipocytes. The former are murine cells that display several distinct metabolic and signal transduction differences compared with human cells. 19 Preadipocytes are obtained from fibroblast-like cells isolated from the stromal portion of human fat tissue which are differentiated in vitro into cells displaying functional traits identical to those of mature fat cells. 11, 14 However, they cannot be expanded and display only a limited life span. Adipocyte research is now focusing on molecular and cellular mechanisms underlying obesity and its consequences. A better understanding of these processes requires large amounts of cells with a metabolism displaying high homology to mature human adipocytes. Nevertheless, it is also important to define possible differences between in vitro differentiated adipocytes and mature fat cells. The molecular mechanisms underlying the results in this study are not entirely clear but are most probably due to altered expression and/or activity. Although mature fat cells and hMSC-derived adipocytes can be obtained in large amounts, a more detailed comparison of signaling pathways between these different cell types would also require large amounts of preadipocytes. Unfortunately, the limited availability of these primary cells prevents us from performing these comparisons.
In summary, we have demonstrated that a2A-AR and PDE3B functions vary with the adipogenic origin of the maturing fat cells. Inhibition of lipolysis through a2A-AR and PDE3B appears to be differentially important for adipocytes obtained from different cellular origins. In hMSC-derived adipocytes, the role of a2A-AR is predominant whereas in mature fat cells PDE3B activity prevails. In preadipocytes both inhibitory pathways are of importance. These signals may play a role for lipid accumulation during adipocyte maturation in order to protect the immature fat cell by inhibiting uncontrolled release of stored energy. Our results demonstrate that there are qualitative differences between human fat cells derived from different precursor cells and that caution should be taken in interpreting results from in vitro adipocyte studies.
